The Department of Chemical Engineering at the University of Virginia is pleased to announce that Barry Buckland will give the 2018 endowed Edward L. Paul Lecture on Industrial Chemical Engineering.

The lecture will be held on Thursday, April 12, 2018 @ 11:00am on the lower level of the Albert and Shirley Small Special Collections Library on the Grounds of the University of Virginia. A reception with light refreshments will be held prior to the lecture (the reception will start at 10:30 am). 

Dr. Barry Buckland obtained his PhD in Biochemical Engineering at University College London in 1974. He joined the Merck Research Laboratories (MRL) in 1980 and built a world-class Bioprocess R&D group. He led process development of all biologically-made product candidates within the MRL pipeline and manufacture of Clinical Supplies during a 20-year time frame; products developed within this period include MEVACOR®, ZOCOR®, IVOMEC®, CANCIDAS®, RECOMBIVAX HB®, VAQTA®, VARIVAX®, COMVAX®., ROTATEQ® (Rotavirus vaccine),  ZOSTAVAX® (shingles vaccine), and GARDASIL® (HPV vaccine). 

Currently, Dr. Buckland is the CEO of BiologicB, holds an appointment as a visiting professor at University College London, volunteers as the chair of the board for Engineering Conferences International, and is the executive director of the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL).

Dr. Buckland was elected into the National Academy of Engineering in 1997 and was named a Fellow of University College London in 1998.  He has been recognized with several additional accolades including:

  • Discoverers Award by the Pharmaceutical Research and Manufacturers of America (PhRMA) for role in discovery and development of Gardasil; one of three recipients, 2009
  • ACS Marvin Johnson Award for Biotechnology, 2008
  • Selected by the American Institute of Chemical Engineering as one of the “One Hundred Chemical Engineers of the Modern Era” (defined as from World War II to the present), 2008
  • Merck Board of Directors award for leading process development for regulatory approval and product launch of 4 major new vaccines, 2007
  • Awarded Donald Medal, UK Institute of Chemical Engineering, 2002
  • Gold Medal Lecture, International Institute of Biotechnology, London, 1994
  • Fellow, American Institute of Medical and Biological Engineering (AIMBE), 1994
The Edward L. Paul Lecture on Industrial Chemical Engineering has been endowed thanks to the generous contributions of individual and corporate donors. The endowment supports 1 or 2 industrially-focused chemical engineering seminars annually. The lecture is named in honor of Dr. Edward L. Paul, a 1952 B.S. graduate of the ChE program at UVA and 1995 winner of the UVA Engineering Distinguished Achievement Award. Dr. Paul developed some of the most innovative pharmaceutical processes in the industry and served as a mentor to scores of chemical engineers during his 40-year tenure at Merck. He is a fellow of the American Institute of Chemical Engineers (AIChE) and is an internationally-recognized expert in the field of mixing and crystallization.